CIPLA
Back to Income Statement
|
CIPLA Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹51.05 | ₹34.71 | ₹31.19 | ₹29.82 | ₹19.18 |
What is the latest Earnings Per Share (EPS) of CIPLA ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2025 | ₹51.05 |
| Mar2024 | ₹34.71 |
| Mar2023 | ₹31.19 |
| Mar2022 | ₹29.82 |
| Mar2021 | ₹19.18 |
How is Earnings Per Share (EPS) of CIPLA Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2025 | ₹51.05 | 47.08 | |
| Mar2024 | ₹34.71 | 11.29 | |
| Mar2023 | ₹31.19 | 4.59 | |
| Mar2022 | ₹29.82 | 55.47 | |
| Mar2021 | ₹19.18 | - | |
Compare Earnings Per Share (EPS) of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹121,529.5 Cr | 0.2% | -0.6% | -3.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,147.0 Cr | 0.2% | 2.3% | -9.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,708.0 Cr | -1.3% | 9.1% | 16.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹121,147.0 Cr | 0.6% | 1% | 10.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,596.0 Cr | 0.6% | -3.5% | -4.3% | Stock Analytics | |
| MANKIND PHARMA | ₹93,419.6 Cr | -5% | -8.8% | -14.2% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | 0.2% |
-0.6% |
-3.8% |
| SENSEX | -1.4% |
1.7% |
4.8% |
You may also like the below Video Courses